Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Much Was The Hemoglobin A1c (HbA1c) Testing Market Worth In 2025, And What Is Its Anticipated Value By 2029?
The hemoglobin a1c (hba1c) testing market has experienced significant expansion in recent years. It is anticipated to grow from $1.83 billion in 2024 to $2.02 billion in 2025, at a compound annual growth rate (CAGR) of 10.4%. The factors contributing to this historic period’s growth include the rising prevalence of diabetes, expanding awareness and screening programs, developing government initiatives and healthcare policies, enhancements in healthcare infrastructure development, an increasing aging population, improved diagnostic accuracy, and the heightened adoption of point-of-care testing.
The hemoglobin a1c (hba1c) testing market size is projected for substantial expansion in the coming years. It is anticipated to reach $3.01 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 10.4%. This anticipated growth during the forecast period is attributable to factors such as the increasing incidence of lifestyle diseases, a heightened emphasis on preventive healthcare, market expansion in developing regions, the rise of personalized medicine and patient-focused care, supportive regulatory frameworks and reimbursement policies, and the expansion of telemedicine and remote monitoring services. Key trends during the forecast timeframe encompass technological innovations, integration with digital health platforms, breakthroughs in non-invasive testing methodologies, and a broadened scope for telehealth and remote patient monitoring.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18632&type=smp
What Are The Emerging Market Drivers Creating New Opportunities In The Hemoglobin A1c (HbA1c) Testing Industry?
The rising occurrence of diabetes is anticipated to drive expansion in the hemoglobin A1c (HbA1c) testing market in the future. Diabetes, a persistent health issue, is characterized by the body’s inability to adequately control blood glucose levels, stemming from either inadequate insulin production or resistance to insulin. The surge in diabetes cases can be attributed to unhealthy dietary habits, particularly the significant intake of processed items and sweetened beverages, alongside inactive lifestyles marked by limited physical movement. Furthermore, an aging demographic and a genetic predisposition through family history contribute to a higher likelihood of developing diabetes. HbA1c testing serves to track prolonged blood glucose management in diabetic patients by determining the average blood sugar concentration over the preceding 2–3 months. For example, in June 2023, figures released by The Lancet, a UK-based publisher of books and periodic data, indicated that worldwide diabetes instances are forecast to climb from 529 million in 2021 to 1.3 billion by 2050. Consequently, the expanding prevalence of diabetes will stimulate the development of the hemoglobin A1c (HbA1c) testing market.
What Are The Major Segment Types Covered In The Hemoglobin A1c (HbA1c) Testing Market?
The hemoglobin a1c (hba1c) testingmarket covered in this report is segmented –
1) By Type: Laboratory Based Testing; Point Of Care (PoC) Testing
2) By Product Type: Instruments; Reagents; Kits
3) By Technology: Immunoassays; Chromatography; Enzymatic Assays; Boronate Affinity Chromatography; High Performance Liquid Chromatography; Other Technologies
4) By End User: Hospitals And Clinics; Diagnostic Laboratories; Homecare Settings; Other End Users
Subsegments:
1) By Laboratory-Based Testing: High-Performance Liquid Chromatography (HPLC) Testing; Ion-Exchange Chromatography; Capillary Electrophoresis; Enzyme-Linked Immunosorbent Assay (ELISA); Mass Spectrometry
2) By Point Of Care (PoC) Testing: Fingerstick Testing Devices; Portable Hba1c Analyzers; Handheld Hba1c Test Kits; Home Use Hba1c Monitoring Devices; Wireless Hba1c Testing Solutions
What Are The Major Trends Driving The Growth Of The Hemoglobin A1c (HbA1c) Testing Market?
Major companies operating in the hemoglobin A1c (HbA1c) testing market are prioritizing technological advancements in diagnostic testing, including HbA1c home tests, to provide more convenient, accurate, and accessible solutions for the early detection and management of diabetes. HbA1c home tests refer to at-home diagnostic kits that allow individuals to measure their average blood sugar levels over the past 2-3 months, aiding in the monitoring and management of diabetes. For instance, in February 2023, Hurdle Health, a US-based company focused on delivering innovative healthcare solutions, including diagnostic tools for chronic disease management, launched the Hemoglobin A1c (HbA1c) Test. This new at-home blood sample test empowers adults to screen and monitor diabetes, advancing Chronomics’ mission to enhance accessibility to diagnostic testing and improve health outcomes through direct-to-consumer solutions.
Which Major Firms Are Strengthening Their Position In The Hemoglobin A1c (HbA1c) Testing Industry?
Major companies operating in the hemoglobin A1c (HbA1c) testing market are Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Tosoh Corporation, Hitachi High-Technologies Corporation, Beckman Coulter Inc, Sysmex Corporation, Bio Rad Laboratories Inc, ARKRAY Inc, Randox Laboratories Ltd, Ortho Clinical Diagnostics, Agappe Diagnostics Ltd, SEKISUI Diagnostics LLC, Helena Laboratories, Transasia Bio Medicals Ltd, EKF Diagnostics, Trinity Biotech plc, HemoCue AB, CPC Diagnostics Pvt Ltd, PTS Diagnostics, Menarini Diagnostics srl, Diazyme Laboratories Inc, Osang HealthCare Co Ltd, Eurolyser Diagnostica GmbH, DiaSys Diagnostic Systems GmbH
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/hemoglobin-a1c-hba1c-testing-global-market-report
Which Region Is Expected To Witness The Fastest Growth In The Hemoglobin A1c (HbA1c) Testing Market?
North America was the largest region in the hemoglobin A1c (HbA1c) testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hemoglobin A1c (HbA1c) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Hemoglobin A1c (HbA1c) Testing Market Report:
https://www.thebusinessresearchcompany.com/customise?id=18632&type=smp
Browse Through More Reports Similar to the Global Hemoglobin A1c (HbA1c) Testing Market 2025, By The Business Research Company
Gmo Testing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/gmo-testing-global-market-report
Dairy Testing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/dairy-testing-global-market-report
Enteric Disease Testing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/enteric-disease-testing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model